Court approves $21.5 mln settlement over Wellbutrin SR
A Pennsylvania federal judge has granted preliminary approval to a deal settling claims that GlaxoSmithKline illegally tried to extend its monopoly on the anti-depressant Wellbutrin SR.Washington – A Pennsylvania federal judge...To view the full article, register now.
Already a subscriber? Click here to view full article